XML 9 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 325,923 $ 351,185
Accounts receivable, net 267,837 206,442
Inventory 161,283 146,362
Prepaid assets 43,163 38,820
Restricted cash 1,103 1,114
Other current assets 12,119 22,408
Total current assets 811,428 766,331
Non-current assets:    
Right-of-use assets 14,994 16,745
Property and equipment, net 4,195 4,345
Other assets 1,313 1,309
Total assets 831,930 788,730
Current liabilities:    
Accounts payable 26,788 37,516
Accrued expenses 101,399 127,806
Current portion of development liability 77,287 75,830
Current portion of lease liabilities 6,257 6,441
Deferred Revenue 3,560  
Total current liabilities 215,291 247,593
Long-term liabilities:    
Long-term development liability 244,426 239,817
Convertible senior notes 93,109 93,033
Lease liabilities 9,770 11,454
Other liabilities 2,658 2,312
Total liabilities 565,254 594,209
Stockholders' equity:    
Preferred stock, $0.0001 par value; 10,000 shares authorized, and zero shares issued and outstanding at March 31, 2024 and December 31, 2023 0 0
Common stock, $0.0001 par value; 200,000 shares authorized at March 31, 2024 and December 31, 2023; 121,267 shares issued and outstanding at March 31, 2024, and 119,556 shares issued and outstanding at December 31, 2023 12 12
Additional paid-in capital 3,174,100 3,035,539
Accumulated other comprehensive loss (3,525) (3,542)
Accumulated deficit (2,903,911) (2,837,488)
Total stockholders' equity 266,676 194,521
Total liabilities and stockholders' equity $ 831,930 $ 788,730